
Aehr Test Systems (AEHR) has wrapped up FY 2026 with fourth quarter revenue of US$18.8 million and EPS of US$0.04, compared with revenue of US$14.1 million and EPS of US$0.10 loss in the prior year’s fourth quarter, while the latest trailing twelve months show revenue of US$50.0 million and an EPS loss of US$0.23. Over the past six reported quarters, the company has seen quarterly revenue range between US$9.9 million and US$18.8 million, with EPS moving between a loss of US$0.11 and a profit of US$0.04 as losses have widened on a multi year basis. With revenue growth expectations running high and profitability still under pressure, investors will be focused on how Aehr Test Systems balances top line opportunity against compressed margins in this latest update.
See our full analysis for Aehr Test Systems.With the headline numbers on the table, the next step is to set Aehr Test Systems' results against the prevailing market narratives to see which stories around growth, risk, and profitability really hold up.
See what the community is saying about Aehr Test Systems
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Aehr Test Systems on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With sentiment split between Aehr Test Systems' growth potential and the pressure from ongoing losses, move quickly to review the numbers yourself and form an independent view backed by the 2 key rewards and 3 important warning signs.
Aehr Test Systems is wrestling with widening multi year losses, a recent trailing twelve month EPS loss of US$0.23, and a premium 12.5x P/B valuation.
If Aehr Test Systems' ongoing losses and valuation premium make you uneasy, shift your attention to companies screened for 82 resilient stocks with low risk scores so your next idea starts on a steadier footing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com